Spot Vision Screener Market, by Indication Type (Myopia, Hyperopia, Astigmatism, Anisometropia, Strabismus, and Anisocoria), By End User (Hospitals, Speciality Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle

Spot Vision Screener Market, by Indication Type (Myopia, Hyperopia, Astigmatism, Anisometropia, Strabismus, and Anisocoria), By End User (Hospitals, Speciality Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Spot vision screener is a handheld, portable device designed to help users quickly and easily detect vision issues in patients above 6 months of age. The spot screener scans eyes from a 3-foot distance. The device has touch-screen display, is easy-to-use, and allows one-touch activation, simple management of patient data entry, and easy configuration for both vision screening and auto refraction applications. The device is used for detection of different eye related indications such as myopia (nearsightedness), hyperopia (farsightedness), astigmatism (blurred vision), anisometropia (unequal refractive power), strabismus (eye misalignment), and anisocoria (unequal pupil size). The U.S Medicare provides reimbursement for spot vision screener devices. The purchase cost of the device is around US$ 7,490, and around US$ 2,500 is average service charges required on an annual basis. The favourable reimbursement and increasing healthcare expenditure by developed and merging economies are expected to drive growth of this market over the forecast period.
Market Dynamics
The key players offering spot vision screener devices are adopting various inorganic growth strategies such as acquisition, agreement, and partnership, which is expected to drive growth of the spot vision screener market. For instance, in September, 2018, Henry Schein Medical, a U.S.-based medical business of Henry Schein, Inc., entered into a distribution agreement with Welch Allyn, a Hill-Rom company, for the distribution of spot vision screener. Spot vision screener is a screening device that can help ophthalmologists to detect early signs of nearsightedness, unequal refractive power, eye misalignment, farsightedness, blurred vision, and unequal pupil size among children as young as six months old.
Similarly, in June 2014, Welch Allyn, Inc. acquired assets of PediaVision Holdings, LLC. PediaVision is a manufacturer of vision technology based devices and develops new generation of user-friendly vision assessment technology that transcends age, developmental capacity, and mobility.
Key features of the study:
This report provides in-depth analysis of the global spot vision screener market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global spot vision screener market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Hillrom, Essilor International S.A., OCULUS Surgical, Inc., FIM Medical, Adaptica S.r.l., Honeywell International Inc., and Plusoptix Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global spot vision screener market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Spot Vision Screener Market, By Indication Type:
Myopia
Hyperopia
Astigmatism
Anisometropia
Strabismus
Anisocoria
Global Spot Vision Screener Market, By End User:
Hospitals
Speciality Centers
Others
Global Spot Vision Screener Market, By Region:
North America
By Country:
U.S.
Canada
By Indication Type:
Myopia
Hyperopia
Astigmatism
Anisometropia
Strabismus
Anisocoria
By End User
Hospitals
Speciality Centers
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Indication Type:
Myopia
Hyperopia
Astigmatism
Anisometropia
Strabismus
Anisocoria
By End User
Hospitals
Speciality Centers
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Indication Type:
Myopia
Hyperopia
Astigmatism
Anisometropia
Strabismus
Anisocoria
By End User
Hospitals
Speciality Centers
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Indication Type:
Myopia
Hyperopia
Astigmatism
Anisometropia
Strabismus
Anisocoria
By End User
Hospitals
Speciality Centers
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Indication Type:
Myopia
Hyperopia
Astigmatism
Anisometropia
Strabismus
Anisocoria
By End User
Hospitals
Speciality Centers
Others
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Indication Type:
Myopia
Hyperopia
Astigmatism
Anisometropia
Strabismus
Anisocoria
By End User
Hospitals
Speciality Centers
Others
Company Profiles
Hillrom*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Essilor International S.A.
OCULUS Surgical, Inc.,
FIM Medical
Adaptica S.r.l.
Honeywell International Inc.
Plusoptix Inc.
“*” marked represents similar segmentation in other categories in the respective section.